Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3R6B

Crystal Structure of Thrombospondin-1 TSR Domains 2 and 3

Summary for 3R6B
Entry DOI10.2210/pdb3r6b/pdb
Related1LSL
DescriptorThrombospondin-1, 1,2-ETHANEDIOL (3 entities in total)
Functional Keywordscell adhesion, disulfide bond, egf-like domain, tsp-1 type 1 repeat
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight17290.27
Authors
Page, R.C.,Klenotic, P.A.,Misra, S.,Silverstein, R.L. (deposition date: 2011-03-21, release date: 2011-08-10, Last modification date: 2023-09-13)
Primary citationKlenotic, P.A.,Page, R.C.,Misra, S.,Silverstein, R.L.
Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system.
Protein Expr.Purif., 80:253-259, 2011
Cited by
PubMed Abstract: The matrix glycoprotein thrombospondin-1 (TSP-1) is a prominent regulator of endothelial cells and angiogenesis. The anti-angiogenic and anti-tumorigenic properties of TSP-1 are in part mediated by the TSP-1 type 1 repeat domains 2 and 3, TSR(2,3). Here, we describe the expression and purification of human TSR(2,3) in milligram quantities from an Escherichia coli expression system. Microvascular endothelial cell migration assays and binding assays with a canonical TSP-1 ligand, histidine-rich glycoprotein (HRGP), indicate that recombinant TSR(2,3) exhibits anti-chemotactic and ligand binding properties similar to full length TSP-1. Furthermore, we determined the structure of E. coli expressed TSR(2,3) by X-ray crystallography at 2.4Å and found the structure to be identical to the existing TSR(2,3) crystal structure determined from a Drosophila expression system. The TSR(2,3) expression and purification protocol developed in this study allows for facile expression of TSR(2,3) for biochemical and biophysical studies, and will aid in the elucidation of the molecular mechanisms of TSP-1 anti-angiogenic and anti-tumorigenic activities.
PubMed: 21821127
DOI: 10.1016/j.pep.2011.07.010
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon